These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32423989)

  • 1. Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.
    McDonald MG; Henderson LM; Ray S; Yeung CK; Johnson AL; Kowalski JP; Hanenberg H; Wiek C; Thummel KE; Rettie AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):233-240. PubMed ID: 32423989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Functional Effects of
    Henderson LM; Hopkins SE; Boyer BB; Thornton TA; Rettie AE; Thummel KE
    Drug Metab Dispos; 2021 May; 49(5):345-352. PubMed ID: 33632714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)-Warfarin.
    Wanounou M; Shaul C; Abu Ghosh Z; Alamia S; Caraco Y
    Clin Pharmacol Ther; 2022 Jul; 112(1):156-163. PubMed ID: 35426132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro.
    Wang L; Bao SH; Pan PP; Xia MM; Chen MC; Liang BQ; Dai DP; Cai JP; Hu GX
    Drug Dev Ind Pharm; 2015; 41(8):1363-7. PubMed ID: 25144335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes.
    Yamazaki H; Inoue K; Chiba K; Ozawa N; Kawai T; Suzuki Y; Goldstein JA; Guengerich FP; Shimada T
    Biochem Pharmacol; 1998 Jul; 56(2):243-51. PubMed ID: 9698079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of phenytoin in 36 CYP2C9 variants found in the Chinese population.
    Chen LG; Wang Z; Zhu Y; Xiong JH; Sun LR; Dai DP; Cai JP; Hu GX
    Chem Biol Interact; 2016 Jun; 253():93-9. PubMed ID: 27163851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of 32 CYP2C9 allelic variants.
    Niinuma Y; Saito T; Takahashi M; Tsukada C; Ito M; Hirasawa N; Hiratsuka M
    Pharmacogenomics J; 2014 Apr; 14(2):107-14. PubMed ID: 23752738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance.
    Shaul C; Blotnick S; Adar L; Muszkat M; Bialer M; Caraco Y
    Clin Pharmacokinet; 2022 Aug; 61(8):1187-1198. PubMed ID: 35699912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profiles.
    Tracy TS; Hutzler JM; Haining RL; Rettie AE; Hummel MA; Dickmann LJ
    Drug Metab Dispos; 2002 Apr; 30(4):385-90. PubMed ID: 11901091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
    Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
    Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel CYP2C9 mutation (1009C>A) detected in a warfarin-sensitive patient.
    Luo SB; Li CB; Dai DP; Wang SH; Wang ZH; Geng PW; Cai J; Jiang ZL; Pu CW; Shang K; Yuan XM; Cao YP; Hu GX; Cai JP
    J Pharmacol Sci; 2014; 125(2):150-6. PubMed ID: 25075423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
    Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.
    Bryk A; Wypasek E; Awsiuk M; Maj D; Undas A
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):257-64. PubMed ID: 25986145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massively parallel characterization of CYP2C9 variant enzyme activity and abundance.
    Amorosi CJ; Chiasson MA; McDonald MG; Wong LH; Sitko KA; Boyle G; Kowalski JP; Rettie AE; Fowler DM; Dunham MJ
    Am J Hum Genet; 2021 Sep; 108(9):1735-1751. PubMed ID: 34314704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of dapsone activation of CYP2C9-catalyzed nonsteroidal anti-inflammatory drug oxidation.
    Nair PC; Burns K; Chau N; McKinnon RA; Miners JO
    J Biol Chem; 2023 Dec; 299(12):105368. PubMed ID: 37866634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites.
    Flora DR; Rettie AE; Brundage RC; Tracy TS
    J Clin Pharmacol; 2017 Mar; 57(3):382-393. PubMed ID: 27539372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of steroids by cytochrome P450 2C9 variants.
    Uno T; Nakano R; Kitagawa R; Okada M; Kanamaru K; Takenaka S; Uno Y; Imaishi H
    Biopharm Drug Dispos; 2018 Sep; 39(8):371-377. PubMed ID: 30098040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.
    Chaudhary N; Kabra M; Gulati S; Gupta YK; Pandey RM; Bhatia BD
    BMC Pediatr; 2016 May; 16():66. PubMed ID: 27179628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.
    Schwarz UI
    Eur J Clin Invest; 2003 Nov; 33 Suppl 2():23-30. PubMed ID: 14641553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62.
    Chen H; Dai DP; Zhou S; Liu J; Wang SH; Wu HL; Zhou Q; Geng PW; Chong J; Lü Y; Cai JP; Yang JF
    Chem Biol Interact; 2020 Aug; 327():109168. PubMed ID: 32531309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.